相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity
Joseph R. Garlich et al.
CANCER RESEARCH (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Pharmacodynamic markers of perifosine efficacy
Bryan T. Hennessy et al.
CLINICAL CANCER RESEARCH (2007)
PIKK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia
Monica Prasad Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies
Paul Workman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Autophagic fungal cell death is necessary for infection by the rice blast fungus
C Veneault-Fourrey et al.
SCIENCE (2006)
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells
M Beloueche-Babari et al.
MOLECULAR CANCER THERAPEUTICS (2006)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts
NT Ihle et al.
MOLECULAR CANCER THERAPEUTICS (2005)
PIK3CA mutations in glioblastoma multiforme
C Hartmann et al.
ACTA NEUROPATHOLOGICA (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
T Kanzawa et al.
CELL DEATH AND DIFFERENTIATION (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
MEK inhibitors: A therapeutic approach to targeting the Ras-MAP kinase pathway in tumors
JS Sebolt-Leopold
CURRENT PHARMACEUTICAL DESIGN (2004)
Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin
P Wipf et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development
S Zoula et al.
NMR IN BIOMEDICINE (2003)
PKB binding proteins: Getting in on the akt
DP Brazil et al.
CELL (2002)
HIF-1 and tumor progression: pathophysiology and therapeutics
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2002)
分享论文
